<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Headache Pain</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Headache Pain</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Headache and Pain</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1129-2369</issn>
      <issn pub-type="epub">1129-2377</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Milan</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">16767537</article-id>
      <article-id pub-id-type="pmc">3476041</article-id>
      <article-id pub-id-type="publisher-id">291</article-id>
      <article-id pub-id-type="doi">10.1007/s10194-006-0291-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Brief Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Spontaneous splenic infarction associated with
sumatriptan use</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Arora</surname>
            <given-names>A.</given-names>
          </name>
          <address>
            <phone>+1-412-578-6929</phone>
            <fax>+1-412-578-6804</fax>
            <email>anjuarora27@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arora</surname>
            <given-names>S.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Department of Internal Medicine, Western Pennsylvania Hospital
Temple University Program, 4800 Friendship Avenue, Pittsburgh, PA 15224 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>6</month>
        <year>2006</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2006</year>
      </pub-date>
      <volume>7</volume>
      <issue>4</issue>
      <fpage>214</fpage>
      <lpage>216</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>4</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>5</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer-Verlag Italia 2006</copyright-statement>
      </permissions>
      <abstract id="Abs1">
        <p>Triptans are specific agonists
of the serotonergic 5-HT<sub>1B/1D</sub>
receptors that have increasingly
been used in the treatment of
migraine and cluster headaches.
Though they are generally considered
safe, there have been a few
reports of myocardial infarction and
stroke associated with triptan use.
We report a patient who developed
spontaneous splenic infarction after
the use of sumatriptan for the treatment
of migraine headache.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Key words</title>
        <kwd>Triptan</kwd>
        <kwd>Spleen</kwd>
        <kwd>Infarction</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag Italia 2006</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
</article>
</pmc-articleset>
